Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection

AIDS

Volumn 10, Issue 10, 1996, Pages 1101-1105

  Mocroft, Amanda ^a   Youle, Michael ^b   Gazzard, Brian ^b   Morcinek, Julian ^b   Halai, Ramesh ^b   Phillips, Andrew N ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HIV Genitourinary Med Research Unit   (United Kingdom)

Author keywords

Aciclovir; Disease progression; Foscarnet; Ganciclovir; Kaposi's sarcoma

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER RISK; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PRIORITY JOURNAL;

ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FOSCARNET; GANCICLOVIR; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SARCOMA, KAPOSI;

EID: 0029812506     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adler MW (Ed): ABC of AIDS (2nd Edn). London: BMJ; 1991.
2. Centers for Disease Control: Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual men - New York City and California. MMWR 1981, 30:305-308.
3. Ziegler JL, Templeton AC, Vogel CL: Kaposi's sarcoma: a comparison of classical, endemic and epidemic forms. Semin Oncol 1984, 11:47-52.
4. Chang Y, Cesarman E, Pessin MS, et al.: Identification of new human herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
5. Ambroziak JA, Blackburn DJ, Herndier BG, et al.: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter]. Science 1995, 268:582-583.
6. Whitby D, Howard MR, Tenant-Flowers M, et al.: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
7. Huang YQ, Li JJ, Kaplan MH, et al.: Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995, 345:759-761.
8. Jones JL, Hanson DL, Chu SY, et al.: AIDS-associated Kaposi's sarcoma. Science 1995, 267:1078-1079.
9. Costagliola D, Mary-Kraus M, for Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodeficience Humaine: Can antiviral agents decrease the occurrence of Kaposi's sarcoma? [letter] Lancet 1995, 346:578.
10. Glesby MJ, Hoover DR, Weng S, et al.: Use of antiherpes drugs and the risk of Kaposi's sarcoma. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September 1995 [abstract LB-16].
11. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-15.
12. Youle MS, Gazzard BG, Johnson MA, et al.: Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. AIDS 1994, 8:641-649.
13. Phillips AN, Pezzotti P, Lepri AC, Rezza G, The Italian Seroconversion Study: CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconvertion Study. AIDS 1994, 8:1299-1305.
14. Jacobson MA, Bachetti P, Kolokathis A, et al.: Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ 1991, 302:73-78.
15. SAS Institute: SAS Users Guide: Statistics, Version 6 (3rd Edn). Cary: SAS Institute, Inc.; 1990.
16. Hanson DL, Chu SY, Farizio KM, et al.: Distribution of CD4+ lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med 1995, 155:1537-1542.